Osimertinib, Non-Small Cell Lung Cancer (NSCLC), EGFR Targeted Therapy, 3rd Generation EGFR-TKI, Irreversible, EGFR Ex19Del, EGFR L858R, CNS Metastasis Resistance,
Sale!
Lucius
Replica Osimertinib EGFR Targeted NSCLC 3rd Gen TKI
Original price was: $685.00.$526.00Current price is: $526.00.
Osimertinib, Non-Small Cell Lung Cancer (NSCLC), EGFR Targeted Therapy, 3rd Generation EGFR-TKI, Irreversible, EGFR Ex19Del, EGFR L858R, CNS Metastasis Resistance,
Reviews
There are no reviews yet.